vabicaserin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2016
012320082016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
UNLABELLED Vabicaserin, a potent 5-HT2C receptor agonist, decreases nucleus accumbens extracellular dopamine levels in rats… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
A quantitative systems pharmacology model that combines in vitro/preclinical neurophysiology data, human imaging data, and… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
2014
2014
The serotonin subtype 2C (5HT2C) receptor is an emerging and promising drug target to treat several disorders of the human… (More)
Is this relevant?
2013
2013
Fibromyalgia is a prevalent musculoskeletal disorder characterized by chronic widespread pain that significantly reduces quality… (More)
Is this relevant?
2013
2013
An efficient, asymmetric synthesis of the 5-HT2C agonist vabicaserin in four chemical steps and 54% overall yield from… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
Is this relevant?
2011
2011
The 5-hydroxytryptamine 2C (5-HT(2C)) receptor subtype has received considerable attention as a target for drug discovery, having… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 5
Is this relevant?
2010
2010
Vabicaserin is a potent 5-hydroxtryptamine 2C full agonist with therapeutic potential for a wide array of psychiatric disorders… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2010
2010
Vabicaserin is a potent 5-hydroxytryptamine(2C) agonist that is currently being developed for the treatment of the psychotic… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2010
2010
Vabicaserin is a potent 5-hydroxtryptamine 2C full agonist with therapeutic potential for a wide array of psychiatric disorders… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
2008
2008
The American Diabetes Association has determined that diabetes costs the United States more than $170 billion per year in… (More)
  • figure 1
Is this relevant?